Tag | Content |
---|
EnhancerAtlas ID | HS060-20353 | Organism | Homo sapiens | Tissue/cell | GM12891 | Coordinate | chr2:175461680-175463370 | | Number of super-enhancer constituents: 31 | ID | Coordinate | Tissue/cell |
SE_04753 | chr2:175460365-175462844 | Brain_Anterior_Caudate | SE_09218 | chr2:175443467-175470051 | CD14 | SE_10373 | chr2:175454641-175466937 | CD19_Primary | SE_10908 | chr2:175440856-175502246 | CD20 | SE_12033 | chr2:175453499-175465667 | CD3 | SE_13074 | chr2:175459879-175463270 | CD34_Primary_RO01480 | SE_13467 | chr2:175454596-175465045 | CD34_Primary_RO01536 | SE_14197 | chr2:175459846-175463624 | CD34_Primary_RO01549 | SE_14618 | chr2:175452847-175466644 | CD4_Memory_Primary_7pool | SE_15552 | chr2:175457516-175465393 | CD4_Memory_Primary_8pool | SE_16127 | chr2:175457264-175463592 | CD4_Naive_Primary_7pool | SE_16370 | chr2:175454842-175464100 | CD4_Naive_Primary_8pool | SE_17112 | chr2:175455893-175465652 | CD4p_CD225int_CD127p_Tmem | SE_17386 | chr2:175449619-175469007 | CD4p_CD25-_CD45RAp_Naive | SE_17852 | chr2:175443580-175468661 | CD4p_CD25-_CD45ROp_Memory | SE_18326 | chr2:175442496-175468710 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19651 | chr2:175453306-175467016 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20138 | chr2:175450234-175466826 | CD56 | SE_21154 | chr2:175454816-175463789 | CD8_Memory_7pool | SE_21724 | chr2:175457403-175463548 | CD8_Naive_7pool | SE_22049 | chr2:175452016-175465654 | CD8_Naive_8pool | SE_22339 | chr2:175449528-175468711 | CD8_primiary | SE_25684 | chr2:175454765-175465656 | DND41 | SE_32656 | chr2:175457263-175465389 | GM12878 | SE_43829 | chr2:175457488-175463989 | MM1S | SE_45857 | chr2:175457434-175463744 | Osteoblasts | SE_58484 | chr2:175442743-175501854 | Ly1 | SE_59799 | chr2:175455191-175487657 | Ly4 | SE_60814 | chr2:175453408-175481611 | DHL6 | SE_61493 | chr2:175457452-175474388 | Toledo | SE_62249 | chr2:175446502-175501370 | Tonsil |
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
| Enhancer Sequence | AATATTTTAT GCCAAAACAT TAATCATATT AAACATAAAG TTATAACTAA TGCTGTAGAA 60 TTTGATTTGC GATAGTAATT GTGCACACAC TGTTATAACA GGAATAGACT TATTCTAAAA 120 GACAAATCGT ATTATAAAAG ACTCTGCTTA GAAATGGTTT AGTTTGAGTT TTGAACTTAA 180 ATAGCACATT GGCAGCAACA GAACTGCAAC AGCTTAGTTC CATGGTATTT TCGTTTGAAG 240 CTTCCAATGG CTCCTTGTAC TTTAAAGCAC TTATTGTTGC TGGCCACACC AAAGATTCAA 300 AGGCAGTTGT GTGGACAACT GTATCATACA CCAAAAGGAT ATATTTACCG ACATAAGCCC 360 CCAATTTAAA TGGGAAAATA AATTCCTGTG GATCCAAACT TGTCCAGTGG TCAAAAAAAT 420 TCTATTGAAA ATCTTGCTTA CATTTTGGCT CAAAGCATAA GTTATGAATC ATTCACAATC 480 ACCATAGTGG TGAAACTAGC ATTCTGGGCA ACAGGAATAG CTCACATGGT GCTCTACAGA 540 AAAATTAAAC AACTTTATCT TGACATACTA TGGTCCATTA AAAGCCATTT AGTTCTTCCC 600 TGTAGCTGAT AAATGAAATA AACTTAGTTT GAATATAATT TTTCTTACCG TTAAAGGGTA 660 CTGCAGGGAG CCATGGTCAG GGACACAGGC AGACAGAGGG CCAGCGGGAC AGGAGCCAAG 720 AGAGAAAACT GTCCCTGAAA AAGGTATCAT CTTCTAACGC AAGTGTGGGG TCGTTTTTGG 780 ACAGCCATTT TGGACAAGCT CTGGCCTCTT GTTAAATGTG ACATACTGAG TCAGAGGCAG 840 ACGTCCTTCT GTGGTTATTC GCTTCCTGTC TGATTAATTT GTTGTTTGTT GTTCCTTCCT 900 CCTTTGCTGC AGAAAAAGAA ACTAGATTGG TTTTGCTTAA GAAGCAAGCA AGAAAAAAAA 960 CCTAAATTAA AAAAAATTAA ATGTTTCTCC TCCCCACAAG GTGTAATACA CAGCTATTTG 1020 GTACAGTGAC AAGAGGAGAT GAGCACCTCC ACTCAGTGAA GAGTCCAACT TTATTCTAGA 1080 TATTCCCACA AAAATAACTG TTCATGGAAC TTGAGATTCC TTTAGGAAAA TTATATTTGA 1140 AAGTATCACT GTAAATACTG ACTATTCCAT TGAGTAATAG GGAAAAGAGT CACTCAAGAA 1200 AGAAAAGCTC TTACCTACCT TACCTTATCG CTTCATTAGG CTAAGGGCTT CTTCTCATTT 1260 ACAGGGCATT CAAGTGTGTG GGGAGAAAGT TACAAATGCA GGTAAAGAGA GCAGGTCAGG 1320 TGTATGAAGG CAAATGAGGT TCTTTTTTTG GTTTTGTTTT ATTTATTTCT TTTTTTTTAG 1380 AGAGACAGTC TTGCTGTCAC TTAGGCTGGA GTGCAGTGGC GTAATCATAG CTCCCTGTGG 1440 CCCTGACCTC CTGGGTTCGA GCAATCCTCC AGCCTCAGCC TCCTGAGTAG CTGAGACTAC 1500 AGGCATATGC CACTGCACCT GGCTAATTTA TTTTATTTTT ATATTTGGTA GAGATGGGAT 1560 CTTGCTTTGT TGCCCAGCCT GGTCTTGCAC TCCTAGCTTC AAAGTGATCC TTCCATCTTA 1620 GCTTCCCAGA TTGCTGGGAT TACAGGCTTG AGCTACCATA CTTGGCAGCA AATGAGTTTT 1680 GAAACGTGAT 1690
|
| |
|
|
|